Log In
Discover
Assets
Jobs
Behance
Pro
Hire Freelancers
Download on the App Store
Get it on Google Play
English
Čeština
Dansk
Deutsch
Español
Français
Italiano
Nederlands
Norsk
Polski
Português
Pусский
Suomi
Svenska
Türkçe
日本語
한국어
中文(简体)
中文(繁體)
About
Blog
TOU
Privacy
Community
Help
Do not sell or share my personal information
Sign Up
Skip to Main Content
Skip to Footer
Behance
Behance
Navigate to behance.net
Explore
Assets
Jobs
Behance
Pro
Hire Freelancers
search
magnifying glass
Sort & filter all:
Projects
Images
People
Assets
People to Hire
Cancel
search
magnifying glass
View your notifications within Behance.
View your notifications within Behance.
Log In
Sign Up
search
magnifying glass
Adobe, Inc.
Adobe, Inc.
Navigate to adobe.com
Follow
Unfollow
Follow
Following
Message
Tools
Illustrator
Tools
Add to Moodboard
Save
Share & Embed This Project
Share
Appreciate
Appreciate
Follow
Following
Unfollow
Follow
Unfollow
Internship at Kurzgesagt – In a Nutshell Part 1
Tobi Frank
•
Follow
Following
Unfollow
Internship at Kurzgesagt – In a Nutshell Part 1
Original storyboard-excerpts of my final project, a video-collaboration with ASAP Science about the most dangerous drugs.
Join Behance
Sign up
or
Sign in
to view personalized recommendations, follow creatives, and more.
Sign Up With Email
Sign Up
or
Join Behance
Sign up
or
Sign in
to view personalized recommendations, follow creatives, and more.
Sign Up With Email
Sign Up
or
Internship at Kurzgesagt – In a Nutshell Part 1
41
1.7k
0
Published:
October 19th 2018
Tobi Frank
Follow
Following
Unfollow
Owner
Tobi Frank
Berlin, Germany
Follow
Following
Unfollow
Message
Internship at Kurzgesagt – In a Nutshell Part 1
Original storyboard-excerpts of my final project, a video-collaboration with ASAP Science about the most dangerous drugs.
41
1.7k
0
Published:
October 19th 2018
Tools
Illustrator
Creative Fields
Illustration
Animation
Motion Graphics
ILLUSTRATION
kurzgesagt
Inanutshell
Drugs
digitalart
animation
storyboard
video
motiondesign
concept
Copyright Info
Attribution, Non-commercial, No Derivatives
Read More
Report